drugset
drugset / Trial / NCT05844618

Short-Term Efficacy of Triamcinolone Acetonide (Aristocort® C) in Subjects with Atopic Dermatitis

NCT05844618 ↗

Phase 4 Completed 20 enrolled Innovaderm Research Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is a randomized, intraindividual study to evaluate the short-term efficacy of triamcinolone acetonide (Aristocort® C) in subjects with atopic dermatitis.

Timeline

Start
2023-05-09
Primary completion
2024-11-07
Completion
2025-03-24

Drugs

EvaluationDrugModalityDoseRoute
Comparator Triamcinolone Acetonide Other / unclassified 3 unknown Topical

Indications

atopic eczema